Global Market Study on HAIs Control: Cleaning and Sterilization to Witness Highest Growth by 2020


  • Published On : Jan-2015 |
  • Pages : 108 Pages |
  • Format :

Hospital-acquired infections (HAIs) refer to the infections that are acquired by patients during their stay in hospitals. These infections are caused by the transmission of pathogens, such as bacteria, viruses, fungi, and parasites, from one patient to another, or from a healthcare worker to a patient. Lack of proper sanitation in hospitals, poor infrastructure, and lack of awareness among healthcare workers are some of the common causes that are boosting the number of HAI cases. In addition, lack of training and poor infection control practices in hospitals also lead to the spreading of HAIs. Some other factors influencing the spread of HAIs include age and nutritional status. Aged people and people suffering from malnutrition have decreased levels of immunity and thus are more prone to acquire HAIs. HAIs are caused by the direct or indirect transmission of microbes. Globally, factors such as increasing government initiatives for controlling HAIs and rising prevalence of HAIs cases have helped in the growth of HAIs market. 

North America dominates the global HAIs market. The U.S. represents the largest market for HAIs control in the North American region. This is due to technical advancements and more focus on improved healthcare facilities in the region. Asia is expected to experience high growth rate in the next five years in HAIs control market. This is due to high prevalence of HAIs in the region and increasing demand for improved healthcare facilities. 

Some of the major factors that are driving the global market for HAIs control market include growing prevalence of HAIs, increasing initiatives by government and non-government organizations and rising aging population. However, factors such as lack of primary healthcare infrastructure in developing countries and lack of awareness about HAIs are restraining the global HAIs control market. Rising number of product launches and increasing popularity of gas plasma sterilization technology are some of the latest trends that have been observed in the global HAIs control market. 

This report provides in-depth analysis and estimation of the HAIs control market for the period 2014 to 2020, considering 2013 as the base year for calculation. In addition, data pertaining to current market dynamics including market drivers, restraints, trends and strategic developments has been provided in the report. The HAIs control market is categorized on the basis of type of method, types of cleaning and sterilization techniques, diagnostics techniques, treatments, diseases and geography. Based on type of cleaning and sterilization techniques, the HAIs control market comprises instrument sterilization, wide-area sterilization, disinfection of linen. Based on type of diagnostic techniques, the market comprises manual testing, automated testing and confirmation testing. Based on the type of pharmaceutical treatment, the market comprises of viral HAI pharmaceuticals, bacterial HAI pharmaceuticals and fungal HAI pharmaceuticals. Based on the type of environmental treatment, the market comprises of air treatment, water treatment and chemical treatment. Based on the type of diseases, the market comprises of pneumonia, gastrointestinal illnesses, urinary tract infections (UTI), surgical site infections and primary bloodstream infections.

In the geographical analysis, the report identifies and analyses market size and forecast of North America, Europe, Asia and Rest of the World (Row). North America is further segmented into the U.S. and rest of North America. Similarly, Europe is further segmented into Germany, France, U.K. and rest of Europe. Asia is further segmented into China, Japan and rest of Asia.

Hospital-acquired infections (HAIs), also known as nosocomial infections, refer to infections that are acquired by patients during their stay in hospitals. Globally, the HAIs control market is witnessing significant growth due to high prevalence of various hospital infections and increasing aging population. In addition, rising number of initiatives undertaken by government and nongovernment organizations and hot and humid environmental conditions are driving the HAIs control market. However, factors such as lack of primary healthcare facilities and infrastructure and limited awareness about HAIs in developing regions are restraining the global market for HAIs control. Increasing popularity of gas plasma sterilization technology is one of the major trends that have been observed in the HAIs control market. The global HAIs control market is estimated at USD 50,807.0 million in 2014. It is likely to grow with a CAGR of 8.5% and reach USD 82,889.4 million in 2020.

North America has the largest market for the HAIs control market. North America market for HAIs control is estimated at USD 21,319.2 million in 2014 and is expected to reach USD 34,430.3 million in 2020, growing at a CAGR of 8.3%. Diagnostic techniques are the largest segment in the overall HAIs control market. In terms of diseases, pneumonia is the largest segment. In terms of growth, Asia is the fastest growing region, cleaning and sterilization is the fastest growing segment and primary bloodstream infections are the fastest growing type of HAIs.

STERIS Corporation is a leading player for cleaning and sterilization in the overall HAIs control market, with a share of about 25% of the cleaning and sterilization market in 2013. Getinge AB accounts for about 24% of the global cleaning and sterilization market for HAIs control. Some of the other major players in HAIs control market are Advanced Sterilization Products Division Ethicon US, LLC, Cepheid, Pfizer, Inc, Hoffmann-La Roche, Ltd., Becton, Dickinson and Company and Kimberly-Clark Corporation.

Some of the major players in the cleaning and sterilization segment in HAIs control market

  • Advanced Sterilization Products Division Ethicon US, LLC.
  • STERIS Corporation.
  • Cepheid.
  • Cantel Medical.
  • Getinge AB.
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • Hoffmann-La Roche, Ltd.
  • Becton, Dickinson and Company.
  • Kimberly-Clark Corporation.
  • bioMerieux SA.
  • Other

Chapter 1 Preface

1.1 Report Description

1.2 Research Methodology

1.3 Assumptions

Chapter 2 Market Synopsis

Chapter 3 Porter’s Five Forces Analysis

3.1 Bargaining Power of Suppliers

3.2 Bargaining Power of Buyers

3.3 Threat of New Entrants

3.4 Threat of Substitutes

3.5 Intensity of Rivalry

Chapter 4 Market Overview

4.1 Market Definition

4.2 Market Drivers

     4.2.1 High prevalence of various hospital infections

     4.2.2 Increasing aging population

     4.2.3 Rising number of initiatives undertaken by government and nongovernment organizations

     4.2.4 Hot and humid environmental conditions

4.3 Impact Analysis of Market Drivers

4.4 Market Restrains

     4.4.1 Lack of primary healthcare facilities and infrastructure

     4.4.2 Limited awareness about HAIs in developing regions

4.5 Impact Analysis of Market Restrains

4.6 Market Trends

     4.6.1 Increasing popularity of gas plasma sterilization technology

     4.6.2 Companies focusing on new product launches

     4.6.3 Increasing number of mergers and acquisitions

4.7 Market Challenges

     4.7.1 Rising number of multi-drug-resistant microbial pathogens

Chapter 5 Global Market Size and Forecast

5.1 On the Basis of Geography

5.2 On the Basis of Type

5.3 On the Basis of Diseases

Chapter 6 Market Size and Forecast by Cleaning and Sterilization

6.1 By Region

6.2 By Type

     6.2.1 Instrument sterilization 

     6.2.2 Wide-area sterilization

     6.2.3 Disinfection of linen

Chapter 7 Market Size and Forecast by Diagnostic Techniques

7.1 By Region

7.2 By Type

     7.2.1 Manual testing

     7.2.2 Automated testing

     7.2.3 Confirmation testing

Chapter 8 Market Size and Forecast by Treatment

8.1 By Region

8.2 By Type

     8.2.1 Pharmaceutical treatment

     8.2.2 Environmental treatment

8.3 By Type of Pharmaceutical Treatment

     8.3.1 Viral HAI pharmaceuticals

     8.3.2 Bacterial HAI pharmaceuticals

     8.3.3 Fungal HAI pharmaceuticals

8.4 By Type of Environmental Treatment

     8.4.1 Air treatment

     8.4.2 Water treatment

     8.4.3 Chemical treatment

Chapter 9 Market Size and Forecast by Disease

9.1 Pneumonia

9.2 Gastrointestinal Illnesses

9.3 Urinary Tract Infections (UTI)

9.4 Surgical Site Infections

9.5 Primary Bloodstream Infections

Chapter 10 Market Size and Forecast by Geography

10.1 North America

10.2 Europe

10.3 Asia 

Chapter 11 Competitive Scenario

11.1 Competitive Benchmarking 

11.2 Company Share Analysis

Chapter 12 Company Profiles 

12.1 Advanced Sterilization Products Division Ethicon US, LLC

     12.1.1 Company overview

     12.1.2 Products and services

     12.1.3 Financial performance

     12.1.4 Key developments 

12.2 STERIS Corporation

     12.2.1 Company overview 

     12.2.2 Product and segments 

     12.2.3 Financial performance 

     12.2.4 Key developments

12.3 Cepheid 

     12.3.1 Company overview

     12.3.2 Products and services

     12.3.3 Financial performance

     12.3.4 Key developments

12.4 Cantel Medical

     12.4.1 Company overview 

     12.4.2 Products and services

     12.4.3 Financial performance

     12.4.4 Key developments

12.5 Getinge AB 

     12.5.1 Company overview

     12.5.2 Products and services

     12.5.3 Financial performance

     12.5.4 Key developments

12.6 Pfizer, Inc.

     12.6.1 Company overview 

     12.6.2 Products and services

     12.6.3 Financial performance 

     12.6.4 Key developments

12.7 Merck & Co., Inc. 

     12.7.1 Company overview 

     12.7.2 Products and services

     12.7.3 Financial performance 

     12.7.4 Key developments

12.8 Hoffmann-La Roche, Ltd.

     12.8.1 Company overview

     12.8.2 Products and services

     12.8.3 Financial performance 

     12.8.4 Key developments

12.9 Becton, Dickinson and Company 

     12.9.1 Company overview

     12.9.2 Products and services 

     12.9.3 Financial performance

     12.9.4 Key developments

12.10 Kimberly-Clark Corporation

     12.10.1 Company overview 

     12.10.2 Products and services 

     12.10.3 Financial performance

     12.10.4 Key developments

12.11 bioMerieux SA

     12.11.1 Company overview

     12.11.2 Products and services

     12.11.3 Financial performance

     12.11.4 Key developments


List of Tables

TABLE 1 Market snapshot: Global market of HAIs control (2014 and 2020)

TABLE 2 Drivers for global HAIs control market: Impact analysis

TABLE 3 Restrains for global HAIs control market: Impact analysis

TABLE 4 Products launched by various companies

TABLE 5 Some mergers and acquisitions in HAIs control market

TABLE 6 Global HAIs control market size, by region, 2010 – 2013 (USD million)

TABLE 7 Global HAIs control market size, by region, 2014 – 2020 (USD million)

TABLE 8 Global HAIs control market size, by type, 2010 – 2013 (USD million)

TABLE 9 Global HAIs control market size, by type, 2014 – 2020 (USD million)

TABLE 10 Global HAIs control market size, by disease, 2010 – 2013 (USD million)

TABLE 11 Global HAIs control market size, by disease, 2014 – 2020 (USD million)

TABLE 12 Global cleaning and sterilization market size, by region, 2010 – 2013 (USD million)

TABLE 13 Global cleaning and sterilization market size, by region, 2014 – 2020 (USD million)

TABLE 14 Global cleaning and sterilization market size, by type, 2010 – 2013 (USD million)

TABLE 15 Global cleaning and sterilization market size, by type, 2014 – 2020 (USD million)

TABLE 16 Global diagnostic techniques market size, by region, 2010 – 2013 (USD million)

TABLE 17 Global diagnostic techniques market size, by region, 2014 – 2020 (USD million)

TABLE 18 Global diagnostic techniques market size, by type, 2010 – 2013 (USD million)

TABLE 19 Global diagnostic techniques market size, by type, 2014 – 2020 (USD million)

TABLE 20 Global HAIs treatment market size, by region, 2010 – 2013 (USD million)

TABLE 21 Global HAIs treatment market size, by region, 2014 – 2020 (USD million)

TABLE 22 Global HAIs treatment market size, by type, 2010 – 2013 (USD million)

TABLE 23 Global HAIs treatment market size, by type, 2014 – 2020 (USD million)

TABLE 24 Global pharmaceutical treatment market size, by type, 2010 – 2013 (USD million)

TABLE 25 Global pharmaceutical treatment market size, by type, 2014 – 2020 (USD million)

TABLE 26 Global environmental treatment market size, by type, 2010 – 2013 (USD million)

TABLE 27 Global environmental treatment market size, by type, 2014 – 2020 (USD million)

TABLE 28 Global pneumonia treatment market size, by region, 2010 – 2013 (USD million)

TABLE 29 Global pneumonia treatment market size, by region, 2014 – 2020 (USD million)

TABLE 30 Global gastrointestinal illnesses treatment market size, by region, 2010 – 2013 (USD million)

TABLE 31 Global gastrointestinal illnesses treatment market size, by region, 2014 – 2020 (USD million)

TABLE 32 Global urinary tract infections treatment market size, by region, 2010 – 2013 (USD million)

TABLE 33 Global urinary tract infections treatment market size, by region, 2014 – 2020 (USD million)

TABLE 34 Global surgical site infections treatment market size, by region, 2010 – 2013 (USD million)

TABLE 35 Global surgical site infections treatment market size, by region, 2014 – 2020 (USD million)

TABLE 36 Global primary bloodstream infections treatment market size, by region, 2010 – 2013 (USD million)

TABLE 37 Global primary bloodstream infections treatment market size, by region, 2014 – 2020 (USD million)

TABLE 38 North American HAIs control market size, by country, 2010 – 2013 (USD million)

TABLE 39 North American HAIs control market size, by country, 2014 – 2020 (USD million)

TABLE 40 European HAIs control market size, by country, 2010 – 2013 (USD million)

TABLE 41 European HAIs control market size, by country, 2014 – 2020 (USD million)

TABLE 42 Asian HAIs control market size, by country, 2010 – 2013 (USD million)

TABLE 43 Asian HAIs control market size, by country, 2014 – 2020 (USD million)

TABLE 44 Major product categories of Advanced Sterilization Products

TABLE 45 Major products categories of STERIS Corporation

TABLE 46 Major product categories of Cepheid

TABLE 47 Major product categories of Cantel Medical

TABLE 48 Major product categories of Getinge AB’s Infection Control business

TABLE 49 Major product categories of Pfizer, Inc.

TABLE 50 Major product categories of Merck & Co., Inc.

TABLE 51 Major product categories of Roche

TABLE 52 Major product categories of Becton, Dickinson and Company

TABLE 53 Major product categories of Kimberly-Clark Corporation

TABLE 54 Major product categories of bioMerieux SA


List of Figures 

FIG. 1 HAI control market: Porter’s five force analysis

FIG. 2 Types of hospital-acquired infections

FIG. 3 Aging population in major countries, 2000 – 2050 (% share in total population)

FIG. 4 Global HAIs control market share, by region, by value, 2013

FIG. 5 Global HAIs control market share, by type, by value, 2013

FIG. 6 Global HAIs control market share, by disease, by value, 2013

FIG. 7 Global cleaning and sterilization market share, by region, by value, 2013

FIG. 8 Global cleaning and sterilization market share, by type, by value, 2013

FIG. 9 Global diagnostic techniques market share, by region, by value, 2013

FIG. 10 Global diagnostic techniques market share, by type, by value, 2013

FIG. 11 Global HAIs treatment market share, by region, by value, 2013

FIG. 12 Global HAIs treatment market share, by type, by value, 2013

FIG. 13 Global pharmaceutical treatment market share, by type, by value, 2013

FIG. 14 Global environment treatment market share, by type, by value, 2013

FIG. 15 Global pneumonia treatment market share, by region, by value, 2013

FIG. 16 Global gastrointestinal illness treatment market share, by region, by value, 2013 

FIG. 17 Global urinary tract infections treatment market share, by region, by value, 2013 

FIG. 18 Global surgical site infections treatment market share, by region, by value, 2013 

FIG. 19 Global primary bloodstream infections treatment market share, by region, by value, 2013

FIG. 20 North American HAIs control market share, by country, by value, 2013

FIG. 21 European HAIs control market share, by country, by value, 2013

FIG. 22 Asian HAIs control market share, by country, by value, 2013

FIG. 23 Competitive landscape of HAIs control products providers, 2013

FIG. 24 Global Cleaning and Sterilization Market, by Company, 2013 (% Share)

FIG. 25 Steris Corporation’s revenue and net income, 2012 – 2014 (USD million)

FIG. 26 Cepheid’s sales and net income/ loss, 2011 – 2013 (USD million)

FIG. 27 Cantel Medical’s net sales and net income, 2011 – 2013 (USD million)

FIG. 28 Getinge ’s net sales and net profit, 2011 – 2013 (USD million)

FIG. 29 Pfizer, Inc.’s revenue and net income, 2011 – 2013 (USD million)

FIG. 30 Merck & Co., Inc.’s sales and net income, 2011 – 2013 (USD million)

FIG. 31 Roche’s sales and net income, 2011 – 2013 (USD million)

FIG. 32 Becton, Dickinson and Company’s revenue and income, 2012 – 2014 (USD million) 

FIG. 33 Kimberly-Clark Corporation’s net sales and net income, 2011 – 2013 (USD million)

FIG. 34 BioMerieux SA’s net sales and net income, 2011 – 2013 (USD million)

Back To Top